CCL5 and breast carcinoma: Another mechanism has been described by Karnoub and colleagues by demonstrating that breast cancer cells stimulated the de novo secretion of the chemokine CCL5 (also named RANTES) from MSCs, which then acted in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis [7].